96 related articles for article (PubMed ID: 23394441)
21. Insulin analogs versus human insulin in type 2 diabetes.
Migdalis IN
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S102-4. PubMed ID: 21864739
[TBL] [Abstract][Full Text] [Related]
22. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
23. Insulin degludec: a novel basal insulin analogue.
Goldman-Levine JD; Patel DK; Schnee DM
Ann Pharmacother; 2013 Feb; 47(2):269-77. PubMed ID: 23386075
[TBL] [Abstract][Full Text] [Related]
24. Diabetes and cancer relationships.
Wang T; Ning G; Bloomgarden Z
J Diabetes; 2013 Dec; 5(4):378-90. PubMed ID: 23574745
[TBL] [Abstract][Full Text] [Related]
25. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
26. Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies.
Wu JW; Filion KB; Azoulay L; Doll MK; Suissa S
Diabetes Care; 2016 Mar; 39(3):486-94. PubMed ID: 26740633
[TBL] [Abstract][Full Text] [Related]
27. Insulin analogues and cancer risk: the emergence of second-generation studies.
Renehan AG
Diabetologia; 2012 Jan; 55(1):7-9. PubMed ID: 22033621
[TBL] [Abstract][Full Text] [Related]
28. Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients.
Morden NE; Liu SK; Smith J; Mackenzie TA; Skinner J; Korc M
Diabetes Care; 2011 Sep; 34(9):1965-71. PubMed ID: 21775752
[TBL] [Abstract][Full Text] [Related]
29. Request for clarification from Ruiter et al regarding 'Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study'.
Carstensen B
Diabetologia; 2012 Mar; 55(3):857-8; author reply 859-60. PubMed ID: 22222505
[No Abstract] [Full Text] [Related]
30. Insulin glargine use and short-term incidence of malignancies - a three-year population-based observation.
Ljung R; Talbäck M; Haglund B; Jonasson JM; Gudbjörnsdòttir S; Steineck G
Acta Oncol; 2011 Jun; 50(5):685-93. PubMed ID: 21506898
[TBL] [Abstract][Full Text] [Related]
31. Critical appraisal of the recent data published on the link between insulin and cancer.
Ghosal S; Stephens J; Van Deventer A; Mital V; Jayasinghe P; Khan M; Setch L; Pauly B
Diabetes Metab Syndr; 2011; 5(4):211-3. PubMed ID: 25572765
[TBL] [Abstract][Full Text] [Related]
32. Hypersensitivity reaction to a biosimilar insulin glargine.
García-Nares H; Leyva-Carmona MI; Pérez-Xochipa N; Chiquete E
J Diabetes; 2015 Mar; 7(2):155-7. PubMed ID: 25350350
[No Abstract] [Full Text] [Related]
33. Risk of breast cancer in patients on long-acting insulin analogues in comparison with those on human insulin.
Kostev K
Diabetologia; 2012 May; 55(5):1554-5. PubMed ID: 22349110
[No Abstract] [Full Text] [Related]
34. Insulin glargine and cancer--an unsubstantiated allegation.
Garg SK; Hirsch IB; Skyler JS
Diabetes Technol Ther; 2009 Aug; 11(8):473-6. PubMed ID: 19591544
[No Abstract] [Full Text] [Related]
35. The metabolic and mitogenic properties of basal insulin analogues.
Tennagels N; Werner U
Arch Physiol Biochem; 2013 Feb; 119(1):1-14. PubMed ID: 23373726
[TBL] [Abstract][Full Text] [Related]
36. Diabetes and pancreatic cancer.
Muniraj T; Chari ST
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):331-45. PubMed ID: 23207610
[TBL] [Abstract][Full Text] [Related]
37. Insulin glargine and cancer: another side to the story?
Gale EA
Lancet; 2009 Aug; 374(9689):521. PubMed ID: 19683632
[No Abstract] [Full Text] [Related]
38. Diabetes and cancer: epidemiology and potential mechanisms.
Joost HG
Diab Vasc Dis Res; 2014 Nov; 11(6):390-4. PubMed ID: 25268021
[TBL] [Abstract][Full Text] [Related]
39. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
Suh S; Kim KW
Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
[TBL] [Abstract][Full Text] [Related]
40. Comment on: Morden et al. Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients. Diabetes Care 2011;34:1965-1971.
Badrick EL; Buchan I; Renehan AG
Diabetes Care; 2012 Feb; 35(2):e15; author reply e16. PubMed ID: 22275452
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
